RenovoRx, Inc. - Common Stock (NQ:RNXT)

1.425 +0.035 (+2.52%)

Delayed Quote Updated: 4:00 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about RenovoRx, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

RenovoRx Eyes 2027 TIGeR-PaC Readout as RenovoCath Expands to 21 Centers ↗

August 16, 2026

RenovoRx (NASDAQ:RNXT) executives and physician speakers discussed the treatment landscape for locally advanced pancreatic cancer, the company’s Trans-Arterial Micro-Perfusion, or TAMP, platform, and...

Via MarketBeat

RenovoRx Q2 Earnings Call Highlights ↗

August 12, 2026

RenovoRx (NASDAQ:RNXT) reported record second-quarter revenue as it expanded its commercial cancer-center network and advanced its clinical program for locally advanced pancreatic cancer. For the...

Via MarketBeat

Topics Earnings

RenovoRx (RNXT) Q2 2026 Earnings Call Transcript ↗

August 12, 2026

Record $909K revenue driven by cancer center expansion and Phase III trial completion.

Via The Motley Fool

Topics Earnings

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Earnings Scheduled For August 14, 2025 ↗

August 14, 2025

Via Benzinga

Earnings Preview For RenovoRx ↗

May 14, 2025

Via Benzinga

RNXT Stock Earnings: RenovoRx Meets EPS for Q2 2024 ↗

August 13, 2024

RNXT stock results show that RenovoRx met analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

RenovoRx (RNXT) Q1 2026 Earnings Transcript ↗

May 19, 2026

RenovoRx (RNXT) Q1 2026 Earnings Transcript

Via The Motley Fool

Top movers in Monday's pre-market session ↗

January 12, 2026

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 14, 2025

Via Benzinga

RENOVORX INC (NASDAQ:RNXT) Reports Significant Q3 2025 Revenue Miss and 5% Stock Drop ↗

November 13, 2025

RenovoRx Q3 2025 earnings show a 35% revenue miss, causing a stock drop. The clinical-stage biopharma provided a 2026 growth outlook to offset cash burn.

Via Chartmill

RenovoRx (RNXT) Q3 2025 Earnings Call Transcript ↗

November 13, 2025

RenovoRx (RNXT) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings Economy

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 10, 2025

Via Benzinga

Top 4 Biotech Stocks Set For A Breakout: Momentum Scores Surge ↗

September 08, 2025

Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Edge Stock Rankings.

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗

September 03, 2025

As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 15, 2025

Via Benzinga

Gapping stocks in Friday's session ↗

August 15, 2025

The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

What's going on in today's pre-market session ↗

August 15, 2025

Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 15, 2025

Via Benzinga

RenovoRx Revenue Jumps 28 Percent in Q2 ↗

August 14, 2025

Via The Motley Fool

Topics Intellectual Property

RenovoRx Inc. (NASDAQ:RNXT) Q2 2025 Earnings: Revenue Surpasses Estimates, Shares Climb on Positive Results ↗

August 14, 2025

RenovoRx (NASDAQ:RNXT) Q2 2025 revenue beats estimates at $422K, shares rise 4.8%. RenovoCath adoption grows, Phase III trial progresses. Strong cash position supports operations.

Via Chartmill

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 27, 2025

Via Benzinga

Earnings Scheduled For May 15, 2025 ↗

May 15, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

April 14, 2025

The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 07, 2025

Via Benzinga

What's going on in today's pre-market session ↗

February 07, 2025

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Via Chartmill

These stocks are moving in today's after hours session ↗

February 06, 2025

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 02, 2024

Via Benzinga

Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday ↗

September 12, 2024

Via Benzinga

Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 14, 2024

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.